Research and Markets has announced the addition of the "Cognitive Impairment - Pipeline Review, H2 2016" report to their offering.
Cognitive Impairment - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Cognitive Impairment, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews of key players involved in therapeutic development for Cognitive Impairment and features dormant and discontinued projects.
Cognitive Impairment Cognitive impairment, also referred to as intellectual disability, describes the condition of a person who has trouble in remembering, learning new things, concentrating, or making decisions that affect their everyday life. Symptoms include memory loss, vision problems, depression, irritability and aggression, anxiety and apathy. The predisposing factors include age, sex, family history and other major risk factors (hypertension, hypercholesterolemia, diabetes mellitus and tobacco) known to be associated frequently with different cerebrovascular diseases, might also contribute to degenerative forms of cognitive impairment.
Cognitive Impairment pipeline therapeutics constitutes close to 119 molecules. Out of which approximately 109 molecules are developed by Companies and remaining by the Universities/Institutes. The molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 15, 25, 2, 53, 11 and 1 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 2, 7 and 1 molecules, respectively.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/mw2f78/cognitive
View source version on businesswire.com: http://www.businesswire.com/news/home/20161024006368/en/Business Wire
Last updated on: 24/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.